MedPath

National Health Insurance Service

🇰🇷South Korea
Ownership
-
Established
1963-01-01
Employees
-
Market Cap
-
Website
http://www.nhic.or.kr/static/html/wbd/g/a/wbdga0101.html

Clinical Trials

3

Active:0
Completed:0

Trial Phases

2 Phases

Phase 3:1
Phase 4:2

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials

Phase 4
2 (66.7%)
Phase 3
1 (33.3%)

Impact of Probiotics on Antibiotic-associated Diarrhea in Community-acquired Pneumonia

Phase 4
Not yet recruiting
Conditions
Pneumonia
Probiotics
Diarrhea
Interventions
Drug: Lacidofil
Drug: Placebo
First Posted Date
2025-05-25
Last Posted Date
2025-05-25
Lead Sponsor
National Health Insurance Service Ilsan Hospital
Target Recruit Count
100
Registration Number
NCT06990568

Adverse Plaque Characteristics in CCTA and TVC Imaging

Phase 4
Conditions
Plaque
Interventions
First Posted Date
2015-01-30
Last Posted Date
2015-10-07
Lead Sponsor
National Health Insurance Service Ilsan Hospital
Target Recruit Count
100
Registration Number
NCT02350959
Locations
🇰🇷

National Health Insurance Service Ilsan Hospital, Goyang-si, Gyeonggi-do, Korea, Republic of

Long Term Prevention of Nausea and Vomiting in Gynecologic Laparoscopy

Phase 3
Conditions
Uterine Myoma, Ovary Neoplasm, Adenomyosis
Interventions
First Posted Date
2013-12-13
Last Posted Date
2013-12-13
Lead Sponsor
National Health Insurance Service Ilsan Hospital
Target Recruit Count
128
Registration Number
NCT02011659
Locations
🇰🇷

National Health Insurance Service Ilsan Hospital, Goyang-si, Korea, Republic of

News

South Korea Accelerates Drug Reimbursement Process with New Pilot Program

South Korea is implementing reforms to reduce drug reimbursement times from approximately 4 years to align more closely with other advanced nations like the US, Japan, and Germany.

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.